The US inactivated vaccines market is supported by strong national immunization programs, advanced vaccine research capabilities, and high healthcare spending. Growing government initiatives to prevent infectious diseases, continuous investments in vaccine development, and the presence of leading pharmaceutical companies are driving the adoption of inactivated vaccines across pediatric and...